Antigen-Dependent Integration of Opposing Proximal TCR-Signaling Cascades Determines the Functional Fate of T Lymphocytes

T cell anergy is a key tolerance mechanism to mitigate unwanted T cell activation against self by rendering lymphocytes functionally inactive following Ag encounter. Ag plays an important role in anergy induction where high supraoptimal doses lead to the unresponsive phenotype. How T cells “measure” Ag dose and how this determines functional output to a given antigenic dose remain unclear. Using multiparametric phospho-flow and mass cytometry, we measured the intracellular phosphorylation-dependent signaling events at a single-cell resolution and studied the phosphorylation levels of key proximal human TCR activation- and inhibition-signaling molecules. We show that the intracellular balance and signal integration between these opposing signaling cascades serve as the molecular switch gauging Ag dose. An Ag density of 100 peptide–MHC complexes/cell was found to be the transition point between dominant activation and inhibition cascades, whereas higher Ag doses induced an anergic functional state. Finally, the neutralization of key inhibitory molecules reversed T cell unresponsiveness and enabled maximal T cell functions, even in the presence of very high Ag doses. This mechanism permits T cells to make integrated “measurements” of Ag dose that determine subsequent functional outcomes.

[1]  D. Speiser,et al.  SHP-1 phosphatase activity counteracts increased T cell receptor affinity. , 2013, The Journal of clinical investigation.

[2]  U. Sivan,et al.  Mixed alkanethiol monolayers on submicrometric gold patterns: a controlled platform for studying cell-ligand interactions. , 2012, Nano letters.

[3]  Sean C. Bendall,et al.  Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes. , 2012, Immunity.

[4]  E. Wherry T cell exhaustion , 2011, Nature Immunology.

[5]  Sean C. Bendall,et al.  Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum , 2011, Science.

[6]  J. Groves,et al.  T-cell triggering thresholds are modulated by the number of antigen within individual T-cell receptor clusters , 2011, Proceedings of the National Academy of Sciences.

[7]  Albert J R Heck,et al.  High-resolution mapping of prostaglandin E2-dependent signaling networks identifies a constitutively active PKA signaling node in CD8+CD45RO+ T cells. , 2010, Blood.

[8]  K. Ravichandran,et al.  A Key Role for the Phosphorylation of Ser440 by the Cyclic AMP-dependent Protein Kinase in Regulating the Activity of the Src Homology 2 Domain-containing Inositol 5′-Phosphatase (SHIP1)* , 2010, The Journal of Biological Chemistry.

[9]  Omer Dushek,et al.  Constitutively Active Lck Kinase in T Cells Drives Antigen Receptor Signal Transduction , 2010, Immunity.

[10]  Ash A. Alizadeh,et al.  B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression , 2010, Proceedings of the National Academy of Sciences.

[11]  E. Borden,et al.  Novel SHP-1 Inhibitors Tyrosine Phosphatase Inhibitor-1 and Analogs with Preclinical Anti-Tumor Activities as Tolerated Oral Agents , 2010, The Journal of Immunology.

[12]  Boris N. Kholodenko,et al.  Signalling ballet in space and time , 2010, Nature Reviews Molecular Cell Biology.

[13]  S. Jameson,et al.  Diversity in T cell memory: an embarrassment of riches. , 2009, Immunity.

[14]  S. Rosenberg,et al.  Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. , 2009, Blood.

[15]  P. Romero,et al.  Expression Hierarchy of T Cell Epitopes from Melanoma Differentiation Antigens: Unexpected High Level Presentation of Tyrosinase-HLA-A2 Complexes Revealed by Peptide-Specific, MHC-Restricted, TCR-Like Antibodies1 , 2009, The Journal of Immunology.

[16]  G. Koretzky,et al.  T cell activation. , 2009, Annual review of immunology.

[17]  E. Klechevsky,et al.  Antitumor activity of immunotoxins with T-cell receptor-like specificity against human melanoma xenografts. , 2008, Cancer research.

[18]  G. Freeman,et al.  PD-1 and its ligands in tolerance and immunity. , 2008, Annual review of immunology.

[19]  Lieping Chen,et al.  Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergy. , 2007, Blood.

[20]  Mark M Davis,et al.  T cells as a self-referential, sensory organ. , 2007, Annual review of immunology.

[21]  M. Bevan,et al.  Effector and memory CTL differentiation. , 2007, Annual review of immunology.

[22]  N. Amariglio,et al.  A Novel Postpriming Regulatory Check Point of Effector/Memory T Cells Dictated through Antigen Density Threshold-Dependent Anergy , 2007, The Journal of Immunology.

[23]  Barbara Hausmann,et al.  Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling , 2006, Nature.

[24]  Philip J. R. Goulder,et al.  PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression , 2006, Nature.

[25]  Rajat Varma,et al.  T cell receptor-proximal signals are sustained in peripheral microclusters and terminated in the central supramolecular activation cluster. , 2006, Immunity.

[26]  R. Schwartz,et al.  Adaptive Tolerance and Clonal Anergy Are Distinct Biochemical States1 , 2006, The Journal of Immunology.

[27]  Takashi Saito,et al.  Newly generated T cell receptor microclusters initiate and sustain T cell activation by recruitment of Zap70 and SLP-76 , 2005, Nature Immunology.

[28]  S. Rosenberg,et al.  Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  U. Lorenz,et al.  Localization of Src Homology 2 Domain-Containing Phosphatase 1 (SHP-1) to Lipid Rafts in T Lymphocytes: Functional Implications and a Role for the SHP-1 Carboxyl Terminus1 , 2005, The Journal of Immunology.

[30]  Timothy K Starr,et al.  Positive and negative selection of T cells. , 2003, Annual review of immunology.

[31]  Mark M. Davis,et al.  Linker for Activation of T Cells, ζ-Associated Protein-70, and Src Homology 2 Domain-Containing Leukocyte Protein-76 are Required for TCR-Induced Microtubule-Organizing Center Polarization1 , 2003, The Journal of Immunology.

[32]  B. Freedman,et al.  Regulation of T Cell Activation and Tolerance by Phospholipase Cγ-1-Dependent Integrin Avidity Modulation1 , 2003, The Journal of Immunology.

[33]  R. Schwartz T cell anergy. , 2003, Annual review of immunology.

[34]  Bernhard Hemmer,et al.  TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways , 2003, Nature Immunology.

[35]  M. Raffeld,et al.  Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes , 2002, Science.

[36]  Anjana Rao,et al.  Transcriptional Mechanisms Underlying Lymphocyte Tolerance , 2002, Cell.

[37]  G. Griffiths,et al.  The immunological synapse of CTL contains a secretory domain and membrane bridges. , 2001, Immunity.

[38]  J. Berzofsky,et al.  An abrupt and concordant initiation of apoptosis: antigen‐dependent death of CD8+ CTL , 2001, European journal of immunology.

[39]  T. Yi,et al.  Sodium Stibogluconate Is a Potent Inhibitor of Protein Tyrosine Phosphatases and Augments Cytokine Responses in Hemopoietic Cell Lines1 , 2001, The Journal of Immunology.

[40]  S. Mok,et al.  Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells. , 2001, Cancer research.

[41]  R. Schwartz,et al.  Adaptive Tolerance of CD4+ T Cells In Vivo: Multiple Thresholds in Response to a Constant Level of Antigen Presentation , 2001, The Journal of Immunology.

[42]  F. Sallusto,et al.  Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. , 2000, Science.

[43]  M. Jenkins,et al.  Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. , 1999, Journal of immunology.

[44]  W. van Eden,et al.  Dose-dependent induction of distinct anergic phenotypes: multiple levels of T cell anergy. , 1999, Journal of immunology.

[45]  Graça Raposo,et al.  Antigen-dependent and -independent Ca2+ Responses Triggered in T Cells by Dendritic Cells Compared with B Cells , 1998, The Journal of experimental medicine.

[46]  M. Silvy,et al.  Differential dose-dependent effects of epidermal growth factor on gene expression in A431 cells: evidence for a signal transduction pathway that can bypass Raf-1 activation. , 1998, Endocrinology.

[47]  D. Haverstick,et al.  Ca2+ Signaling Modulates Cytolytic T Lymphocyte Effector Functions , 1998, The Journal of experimental medicine.

[48]  Dennis R. Merkley,et al.  Dynamics of Oxidation of a Fe2+-Bearing Aluminosilicate (Basaltic) Melt , 1996, Science.

[49]  K. Siminovitch,et al.  Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase , 1996, The Journal of experimental medicine.

[50]  Antonio Lanzavecchia,et al.  T Cell Activation Determined by T Cell Receptor Number and Tunable Thresholds , 1996, Science.

[51]  D. Plas,et al.  Direct Regulation of ZAP-70 by SHP-1 in T Cell Antigen Receptor Signaling , 1996, Science.

[52]  A. Lanzavecchia,et al.  Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy , 1996, The Journal of experimental medicine.

[53]  M. Esser,et al.  Distinct T cell receptor signaling requirements for perforin- or FasL- mediated cytotoxicity , 1996, The Journal of experimental medicine.

[54]  Mary L. Thomas,et al.  Biphasic actions of estrogen on colon cancer cell growth: possible mediation by high- and low-affinity estrogen binding sites , 1995, Endocrine.

[55]  G. Schönrich,et al.  Levels of peripheral T cell tolerance induced by different doses of tolerogen. , 1994, Science.

[56]  D. Cantrell,et al.  T-cell activation. , 1992, Trends in cell biology.

[57]  R. Germain,et al.  Split anergy in a CD8+ T cell: receptor-dependent cytolysis in the absence of interleukin-2 production. , 1991, Science.

[58]  B. Rocha,et al.  Peripheral selection of the T cell repertoire. , 1991, Science.

[59]  M. Niks,et al.  Quantification of proliferative and suppressive responses of human T lymphocytes following ConA stimulation. , 1990, Journal of immunological methods.

[60]  Peter O. Krutzik,et al.  Phospho flow cytometry methods for the analysis of kinase signaling in cell lines and primary human blood samples. , 2011, Methods in molecular biology.

[61]  Omer Dushek,et al.  Mechanisms for T cell receptor triggering , 2011, Nature Reviews Immunology.

[62]  J. Schachter,et al.  Modifying interleukin-2 concentrations during culture improves function of T cells for adoptive immunotherapy. , 2009, Cytotherapy.

[63]  E. Calabrese Hormetic dose-response relationships in immunology: occurrence, quantitative features of the dose response, mechanistic foundations, and clinical implications. , 2005, Critical reviews in toxicology.

[64]  Garry P Nolan,et al.  Flow cytometric analysis of kinase signaling cascades. , 2004, Methods in molecular biology.

[65]  S. Rosenberg,et al.  Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanoma. , 2000, Journal of immunotherapy.